Yunji Announces Fourth Quarter and Fiscal Year 2024 Unaudited Financial Results
1. Yunji's Q4 2024 revenue fell 35% year-over-year. 2. Loss from operations increased to RMB77.7 million. 3. Management focuses on high-margin organic health products. 4. Repeat purchase rate remains strong at 71.9%. 5. Operational cost structure optimizations are underway.